Transforming growth factor-beta and the immune response: implications for anticancer therapy.
about
Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunityMesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationImproving the clinical impact of biomaterials in cancer immunotherapy.Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleTargeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityBone metastases: When and how lung cancer interacts with boneTransforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cellsCombining radiotherapy and cancer immunotherapy: a paradigm shiftThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationSwitching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker StudiesRole of TGFβ in regulation of the tumor microenvironment and drug delivery (review)TGFbeta in CancerProstate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.Regulation of tumor immune surveillance and tumor immune subversion by tgf-BetaTwo faces of TGF-beta1 in breast cancer.Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal FibrosisTransforming growth factor beta (TGF-beta) and inflammation in cancer.Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.Vaccines against human carcinomas: strategies to improve antitumor immune responses.Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Resveratrol, MicroRNAs, Inflammation, and Cancer.Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expressionTGFβ in T cell biology and tumor immunity: Angel or devil?T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.DC expressing transgene Foxp3 are regulatory APC.Histone deacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellular signal-regulated kinase 1/2A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsRole of transforming growth factor Beta in corneal function, biology and pathologyNovel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.Transforming growth factor-β and the hallmarks of cancer.The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cellsGastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications.CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma.Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.Targeting the tumor microenvironment to enhance antitumor immune responsesBlockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
P2860
Q24642507-722C14DD-0295-4029-A9BA-010BBAA5D29BQ26741252-8247E3B4-14F9-43AF-94C1-53B655955646Q26766267-E1046E41-2F3B-4887-A14B-4EFA74AC092FQ26769734-8C1AED42-7BE8-4AE7-AE22-31905BE20918Q26797280-ADBE2010-F21E-47BF-B16B-CBAA507FA490Q26823287-86D1C231-FB32-4170-9DD0-4E02E06E5F6CQ26996742-C5D42430-1DDD-4EF3-893F-8F486291FC42Q27021428-1787643C-2224-46D9-99D3-1812B7061F54Q27024106-CDFB0B92-B09B-48BF-9769-8281CC7E4112Q28079488-E774FAA6-3CA0-498A-B5CE-58C90C2E7BD4Q28081170-0B0A5DC7-7BE0-4E69-B0E8-41500F80C238Q28288866-9B4C09AB-3EAF-4FE4-BA34-ED583BFB9505Q33606027-263E7E93-9603-49E8-BF9C-CA4C71BF2F25Q33631922-906AA61B-751F-4CAC-B7CB-859586D7DD74Q33661529-AFC08A0A-A00D-47F4-84FB-EC8C4067638BQ33701827-6430701E-B275-4F1A-8185-A26633B495ECQ33712568-A092607E-F0C7-432B-A55D-EA7DAE8011AEQ33715943-0C334296-1090-4800-BA77-1BBD6724BCF5Q33734281-D3746E3D-658F-405A-B63C-02DA1D1D4505Q33772507-381A6962-6A54-4542-9105-DF84AB0BBDC9Q34084756-642BD14A-4A7A-49D1-A78F-0BBEA720F711Q34208358-6361CFC2-E1A8-40D3-AFA9-D5A5BCEA0AD6Q34240499-3F046EE8-797A-4E50-A297-E8E97D012A75Q34276027-2E697697-5BC4-49ED-A482-A09D5002DECAQ34343664-027FF3F4-E16C-4DAC-8F3B-A5A63273E065Q34503547-90CDB2BD-6BE7-4DFF-88F2-8BC6FF075261Q34545336-F727ED9E-CEF1-4B81-BA35-40D42D059C28Q34570094-32A08D3C-EFC5-4D5B-9C24-5D6CEAE48636Q34623130-B05087DB-C709-4C18-B3DA-302206C98A38Q34634172-AD6D5169-8763-4011-A2C6-5BD984102AB5Q34756669-0DF80EAF-13A6-47F1-B886-C9916F83276CQ34789300-0F76C249-A56C-4ACA-89B3-D5DDB75E7D25Q34832951-279A8ED7-FCAD-4DA3-8715-8385BB7C3CDDQ34863376-4B3530E2-9B05-4D60-A3FC-F90F66041CA4Q35076034-E4E4E27E-8D5F-4AFC-AB15-BFA9AB172F49Q35112793-7E3FE0DD-DD4E-450A-9EAF-FF99758603F2Q35117549-807A7D2B-ED96-4CCA-B4C3-D01A195C3B38Q35163556-D7F09E6D-2F9E-4627-AE47-166BDFCF1564Q35176307-6F5B018A-7272-4FCA-9D7F-C611094EBC3BQ35474102-77B5693D-91E3-4672-82D5-CF4C5C6D1EB2
P2860
Transforming growth factor-beta and the immune response: implications for anticancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Transforming growth factor-bet ...... ations for anticancer therapy.
@en
type
label
Transforming growth factor-bet ...... ations for anticancer therapy.
@en
prefLabel
Transforming growth factor-bet ...... ations for anticancer therapy.
@en
P2093
P1476
Transforming growth factor-bet ...... ations for anticancer therapy.
@en
P2093
Richard A Flavell
Stephen H Wrzesinski
Yisong Y Wan
P304
P356
10.1158/1078-0432.CCR-07-1157
P407
P433
P577
2007-09-01T00:00:00Z